Digital storytelling program for teenage childhood cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adolescents who have completed cancer treatment will be assigned to a digital storytelling intervention or to usual care. Participants in the intervention arm will join groups of 6 to 8 for four 2.5-hour workshops led by a qualified interventionist to create and share personal digital stories. Parents do not attend workshops but are provided a waiting area and a leaflet with self-help material for depression; the control group receives customary medical follow-up and nursing care. Outcomes include measures of depressive symptoms, self-esteem, and quality of life collected before and after the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* (1) age between 13 and 18 years;
* (2) able to speak Cantonese and read Chinese; and
* (3) completed the active treatment of cancer.

Exclusion Criteria:

* survivors with mental and behavioural problems documented in their medical records.

Where it's running

• The Hong Kong Polytechnic University,
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Ka Yan Ho, phd — The Hong Kong Polytechnic University
• Study coordinator: Ka Yan Ho, PhD
• Email: kyeva.ho@polyu.edu.hk
• Phone: +8527666417

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.